Target viruses

Expand your antiviral and vaccine development pipelines. We can test the efficacy of candidate antiviral drugs and vaccines against a variety of viruses, including:

• Arboviruses (such as Dengue virus, West Nile virus, Japanese encephalitis virus, Tick-borne encephalitis virus, Yellow fever virus, Zika virus, Chikungunya virus, Ross River fever virus)
• Zoonotic viruses (such as Rabies virus, Influenza virus, MERS coronavirus, SARS coronavirus, SARS-CoV-2)
• Other respiratory viruses (such as Respiratory syncytial virus, Human metapneumovirus)
• Herpesviruses (such as Cytomegalovirus, Epstein-Barr virus).

In vivo experiments and studies

Animal models are necessary for the stratification of products in development and evaluation of the immunogenicity, efficacy and safety of candidate drugs or vaccines.

We offer preclinical studies in a range of animal species, including inbred, outbred and humanised mice, cotton rats, rabbits, and ferrets.

In vitro experiments and testing

Artemis Bioservices uses tailor-made and routinely developed assays for testing samples collected from animal studies and clinical studies.

Artemis Bioservices also offers the possibility to test your products in 2D and 3D cell culture models derived from stem cells and primary cells.

Leishmania expression system

The non-pathogenic Leishmania expression system innovatively offers unique advantages associated with its innoucity for humans and the environment, ease to cultivate, industrial scalability,  high yields and cost-effectiveness. It guarantees the production of relevant forms of eukaryotic proteins.

Bacterial and mammalian expression systems

Bacterial & mammalian expression systems are routinely used in many laboratories. Most common transient systems are available at Artemis Bioservices.

Vaccine preparations

Artemis Bioservices assists you with the development of experimental recombinant protein vaccines. We prepare the desired vaccine formulation in view of vaccination or challenge experiments in the appropriate animal model.

Standardized virological assays

Valid comparison of immunogenicity and efficacy across vaccine candidates or preclinical models will be obtained by conducting head-to-head analysis using a standardized assay that has equivalent sensitivity and specificity for different host species.

Artemis Bioservices can advise you on the choice of commercially available assay, or can assist you by developing tailored-made assays that are highly optimized for sensitivity, specificity, precision, reproducibility, and robustness.

Quantitative PCR

Artemis Bioservices offers a tailor-made package of quantitative PCR (qPCR) for detection of viral load in preclinical and clinical samples. Quantifying the viral load upon infection is an important measure to assess vaccine and antiviral drug efficacy. We also routinely perform virus isolation, titration and sequence analysis.